Literature DB >> 23840156

Azathioprine-induced fever in autoimmune hepatitis.

Tawfik Khoury1, Jacob E Ollech, Shmuel Chen, Meir Mizrahi, Meir Shalit.   

Abstract

Underdiagnosis of drug-induced fever leads to extensive investigation and prolongation of hospitalization, and may lead to multiple unnecessary invasive procedures and a wrong diagnosis. Azathioprine is a widely used immunosuppressive drug. We report a case of a 53-year-old female patient diagnosed with autoimmune hepatitis treated with azathioprine, who presented to the emergency room with a 6-wk history of fever and chills without other associated symptoms. Since the patient's fever was of unknown origin, she was hospitalized. All treatment was stopped and an extensive workup to explore the source of fever and chills was performed. Results of chest X-ray, viral, urine, and blood cultures, autoimmune serology, transthoracic and transesophageal echocardiography, and abdominal ultrasound revealed no source of infection. A rechallenge test of azathioprine was performed and the fever and chills returned within a few hours. Azathioprine was established as the definite cause following rechallenge. Fever as an adverse drug reaction is often unrecognized. Azathioprine has been reported to cause drug-induced fever in patients with inflammatory bowel disease, rheumatoid arthritis, and sarcoidosis. To the best of our knowledge there have been no previous reports documenting azathioprine-induced fever in patients with autoimmune hepatitis. The occurrence of fever following the readministration of azathioprine suggests the diagnosis of drug-induced fever, particularly after the exclusion of other causes. A careful rechallenge is recommended to confirm the diagnosis.

Entities:  

Keywords:  Adverse drug reactions; Autoimmune hepatitis; Azathioprine; Drug fever

Mesh:

Substances:

Year:  2013        PMID: 23840156      PMCID: PMC3703198          DOI: 10.3748/wjg.v19.i25.4083

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Azathioprine hypersensitivity mimicking underlying inflammatory bowel disease.

Authors:  M Corbett; M Schlup
Journal:  Intern Med J       Date:  2001-08       Impact factor: 2.048

Review 2.  Drug fever.

Authors:  D H Johnson; B A Cunha
Journal:  Infect Dis Clin North Am       Date:  1996-03       Impact factor: 5.982

Review 3.  The neurologic basis of fever.

Authors:  C B Saper; C D Breder
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

Review 4.  Understanding drug-induced febrile reactions.

Authors:  M K Roush; K M Nelson
Journal:  Am Pharm       Date:  1993-10

Review 5.  Drug fever. Remember to consider it in diagnosis.

Authors:  M A Hanson
Journal:  Postgrad Med       Date:  1991-04       Impact factor: 3.840

6.  Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis.

Authors:  M E Jeurissen; A M Boerbooms; L B van de Putte; M W Kruijsen
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

7.  Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.

Authors:  Harpreet K Dhaliwal; Rory Anderson; Elizabeth L Thornhill; Sarah Schneider; Elaine McFarlane; Dermot Gleeson; Lynne Lennard
Journal:  Hepatology       Date:  2012-09-07       Impact factor: 17.425

8.  Drug fever: a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature.

Authors:  P A Mackowiak; C F LeMaistre
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

Review 9.  Drug hypersensitivity reactions and human immunodeficiency virus disease.

Authors:  P J Bayard; T G Berger; M A Jacobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992-12

10.  Fever and rigors as sole symptoms of azathioprine hypersensitivity.

Authors:  P J Smak Gregoor; J L van Saase; W Weimar; P Kramer
Journal:  Neth J Med       Date:  1995-12       Impact factor: 1.422

View more
  1 in total

1.  Reutilization of Fe-containing tailings ore enriched by iron(iii) chloride as a heterogeneous Fenton catalyst for decolorization of organic dyes.

Authors:  Lan Huong Nguyen; Quoc Nguyen Ngo; Huu Tap Van; Van Nam Thai; Tan Phong Nguyen; Kieu Oanh Phan Thi
Journal:  RSC Adv       Date:  2021-04-28       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.